Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ADC Therapeutics (ADCT) Inventory Average (2021 - 2026)

ADC Therapeutics has reported Inventory Average over the past 6 years, most recently at $4.5 million for Q1 2026.

  • Quarterly results put Inventory Average at $4.5 million for Q1 2026, down 54.51% from a year ago — trailing twelve months through Mar 2026 was $4.5 million (down 54.51% YoY), and the annual figure for FY2025 was $3.2 million, down 65.08%.
  • Inventory Average reached $4.5 million in Q1 2026 per ADCT's latest filing, down from $11.1 million in the prior quarter.
  • Across five years, Inventory Average topped out at $21.1 million in Q3 2023 and bottomed at $4.4 million in Q1 2022.
  • Median Inventory Average over the past 5 years was $15.6 million (2024), compared with a mean of $13.9 million.
  • The largest annual shift saw Inventory Average skyrocketed 193178.65% in 2022 before it crashed 54.51% in 2026.
  • Over 5 years, Inventory Average stood at $15.9 million in 2022, then rose by 22.3% to $19.5 million in 2023, then plummeted by 52.9% to $9.2 million in 2024, then grew by 21.3% to $11.1 million in 2025, then crashed by 59.69% to $4.5 million in 2026.
  • Business Quant data shows Inventory Average for ADCT at $4.5 million in Q1 2026, $11.1 million in Q4 2025, and $17.9 million in Q3 2025.